Self‑Medication in Peru During the COVID‑19 Pandemic: How Harmless It Could Be?
Abstract
Keywords
Full Text:
PDFReferences
Onchonga D. A Google trends study on the interest in
self‑medication during the 2019 novel coronavirus (COVID‑19)
disease pandemic. Saudi Pharm J 2020;28:903‑4.
Ruiz ME. Risks of self‑medication practices. Curr Drug Safety
;5:315‑23.
Urrunaga‑Pastor D, Benites‑Zapata VA, Mezones‑Holguín E.
Factors associated with self‑medication in users of drugstores
and pharmacies in Peru: An analysis of the National Survey
on User Satisfaction of Health Services, ENSUSALUD 2015.
F1000Res 2019;8:23.
Alvarez‑Risco A, Mejia CR, Delgado‑Zegarra J,
Del‑Aguila‑Arcentales S, Arce‑Esquivel AA,
Valladares‑Garrido MJ, et al. The Peru approach against the
COVID‑19 Infodemic: Insights and Strategies. Am J Trop Med
Hyg 2020;103:583‑6.
Hernandez AV, Roman YM, Pasupuleti V, Barboza JJ,
White CM. Hydroxychloroquine or chloroquine for treatment or
prophylaxis of COVID‑19: A living systematic review. Ann Inter
Med 2020;173:287‑96.
Martinez-Rivera RN, Taype-Rondan A. Overmedication in
COVID-19 context: A report from Peru. J Clin Pharmacol 2020. doi: 10.1002/jcph. 1704.
Lexicomp Online, Lexi‑Drugs Online, Hudson, Ohio: UpToDate,
Inc.; 2020; May 30, 2020.
Mbuagbaw L, Mursleen S, Lytvyn L, Smieja M, Dolovich L,
Thabane L. Mobile phone text messaging interventions for HIV
and other chronic diseases: An overview of systematic reviews
and framework for evidence transfer. BMC Health Serv Res
;15:33.